The CTNNB1 gene gives cells instructions for a protein that helps cells stick together and helps guide growth, especially in the brain. If this gene does not work properly, some people have a neurodevelopmental condition with delayed walking and speech, low muscle tone, learning difficulties, and sometimes vision or behavior differences. This gene plays an important role in the body’s cell growth signals, so non inherited variants in the CTNNB1 gene can also be found in some cancers.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for building proteins, which are the working parts of cells. Other genes mostly regulate when certain processes take place, where they occur, and how strongly they operate. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
CTNNB1Gene function
What if the gene works
The CTNNB1 gene helps cells stick together and pass growth signals. Its protein supports normal body development and helps tissues maintain their structure.
Risk
What if the gene does not work
Depending on the variant, changes in the CTNNB1 gene can cause a neurodevelopmental condition with delayed development, intellectual disability, movement differences, and eye findings, ranging from milder to more marked. Some acquired variants are also linked to certain tumors.
Treatment
What does that mean for your treatment
No CTNNB1-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the CTNNB1 gene. Separately, the CTNNB1 gene is being studied as a tumor biomarker and drug target in some cancers, mainly when the gene is overactive rather than lost.
Conditions associated with CTNNB1
Gene function
What if the gene works
Your tissues work best when cells stay connected and respond to the right growth cues at the right time. The CTNNB1 gene supports both jobs through a protein called beta-catenin. This helps explain how the CTNNB1 gene helps cells stick together and respond to growth signals in everyday tissue growth, repair, and development.
The CTNNB1 gene helps neighboring cells stay attached at their surfaces. Its protein links these attachment points to the cell’s inner scaffold, which helps tissues keep their shape and strength.
The CTNNB1 gene also helps pass along Wnt signals, a set of growth messages used during development and tissue renewal. When these messages arrive, its protein can help switch on the right genes in the nucleus (the cell’s control center).
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
CTNNB1 gene variants can alter how beta catenin is made, folded, or broken down, which changes how well it binds other proteins and signals inside cells. Some variants shorten the protein or sharply reduce its amount, while milder variants may leave some activity intact. This range helps explain how CTNNB1 gene variants affect protein function and, in CTNNB1 related conditions, may influence how early features appear and how broad they are.
How variants are linked to conditions
Pathogenic variants in the CTNNB1 gene can cause CTNNB1 syndrome, a neurodevelopmental condition linked to developmental delay, speech and learning difficulties, low muscle tone, and later stiffness in the legs. Some people also have small head size, autism features, or both. Variants in the CTNNB1 gene are also linked to vision problems, including familial exudative vitreoretinopathy, an inherited condition affecting the retina. How CTNNB1 gene variants are linked to conditions can vary by the specific variant and by the person.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely found across the population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant tied to a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CTNNB1-related conditions, risk is usually driven mainly by the gene change itself, and most cases happen as a new change rather than being caused by lifestyle or environmental factors. Family history can raise the chance if a parent carries the CTNNB1 change, including in some egg or sperm cells, but this is uncommon.
Inheritance of CTNNB1 variants
CTNNB1-related conditions are usually inherited in an autosomal dominant pattern, which means a variant in one copy of the CTNNB1 gene can be enough to cause the condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. In many families, though, CTNNB1-related neurodevelopmental conditions happen because of a new (de novo) variant, so the change was not inherited from either parent. This is the main answer to how CTNNB1 gene variants are inherited.
What does my CTNNB1 result mean for my family?
For CTNNB1, the main known condition usually follows a dominant pattern, so a parent with the same gene change can pass it on to a child. In many families, though, the change happens for the first time in the child and is not found in either parent. This means close relatives may or may not carry the same change, and the family implications depend on whether it was inherited or new.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CTNNB1 gene, doctors use genetic testing for CTNNB1 variants, usually on a blood sample or cheek swab. A lab reads the gene’s DNA code and compares it with the usual sequence to look for variants. Results may show a variant that helps explain a person’s condition or no relevant variant.
When should I consider getting a genetic test?
Genetic testing for the CTNNB1 gene may be worth considering if a child has unexplained developmental delay, low muscle tone, speech delay, trouble walking, or vision problems, especially when several of these occur together. It can help explain the cause of these challenges and support care and family planning.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it explains varies depending on the condition and the specific type of variant. Lifestyle, environment, age, and medical history also shape how the body works over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug faster or more slowly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person but not as well for another, or why side effects can differ. These differences are common and are one part of how the body handles medication.
What is Pharmacogenetics?
Pharmacogenetics explores how differences in genes can shape a person’s response to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how strongly a drug works or how the body processes it. This information can help guide more informed, individualized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the CTNNB1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or treatment changes are best discussed with your doctor. In cancer research, CTNNB1 changes are being studied because they may affect how some tumors respond to treatments such as immunotherapy, but this is not yet a standard part of care.
History
The CTNNB1 gene entered medical research through two lines of work that later came together. In the late 1980s and early 1990s, scientists studying cell adhesion identified beta catenin as part of the machinery that helps cells stick together, while cancer researchers linked related signaling pathways to tumor growth. Building on this early work, scientists uncovered more about the gene. During the 1990s, CTNNB1 became recognized as a key player in the Wnt pathway, an important signaling system in development and cancer biology. Researchers then connected variants in the CTNNB1 gene with certain tumors and, later, with a neurodevelopmental condition affecting movement, learning, and behavior. This history made CTNNB1 important in both basic biology and clinical genetics.